PPARγ maintains ERBB2-positive breast cancer stem cells

Overexpression of the adverse prognostic marker ERBB2 occurs in 30% of breast cancers and is associated with aggressive disease and poor outcomes. Our recent findings have shown that NR1D1 and the peroxisome proliferator-activated receptor-γ (PPARγ)-binding protein (PBP) act through a common pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, X, Sun, Y, Wong, J, Conklin, D S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898098/
https://www.ncbi.nlm.nih.gov/pubmed/23770845
http://dx.doi.org/10.1038/onc.2013.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898098/
https://www.ncbi.nlm.nih.gov/pubmed/23770845
http://dx.doi.org/10.1038/onc.2013.217

Ejemplares similares